The invention relates to a humanized anti-B7-2 antibody that comprises a variable region of nonhuman origin and at least a portion of an immunoglobulin of human origin. The invention also pertains to methods of treatment for various autoimmune diseases, transplant rejection, inflammatory disorders and infectious diseases by administering humanized anti-B7-2 and/or anti-B7-1 antibodies.

 
Web www.patentalert.com

< Treatment of diseases involving faulty MHC class I antigen complex presentation

< Vaccine for the prevention of bacterial infection of the bovine mammary gland

> Adhesion deficient isolate of Flavobacterium columnare against columnaris disease

> Composition and methods for WTI specific immunotherapy
~ 00231